A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

NCT02790138 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Pouchitis

Interventions

DRUG: Vedolizumab Placebo
DRUG: Ciprofloxacin
DRUG: Vedolizumab

Sponsor

Takeda